New Year’s Resolutions for the Regenerative Medicine Industry

Posted on January 2, 2008 by jrowley

With the New Year upon us, I thought it would be good to make a set of New Year’s Resolutions for the regenerative medicine industry. This set of resolutions is not company specific, but things that will be required to build long term value for this nascent industry. Get those marketing people working: Any way [...]

Filed under: business models, Innovation, Regenerative Medicine | Tagged: , , , | 2 Comments »

Patent Reform Act of 2007 – Impact on Regenerative Medicine

Posted on December 7, 2007 by jrowley

The author of CELLWISE, one of the newer bio-Blogs out there, asked a question related to the Patent Reform Act of 2007 in a comment on the Pfizer post. He asked: The article that is cited is right; our patent system is not optimized for today’s innovations or our different industries. The patent office is [...]

Filed under: Big Pharma, Innovation, Intellectual Property, Regenerative Medicine | Tagged: , , , , | 1 Comment »

Pfizer Launches Independent BioInnovation Center

Posted on December 1, 2007 by jrowley

Pfizer Global Research and Development (PGRD) has been going through some major restructuring, and in an effort to spur innovation has opened an independent research center in the Bay Area. This “biotherapeutics and bioinnovation center” will be headed up by experienced bioentrepreneur Corey Goodman. Is it possible that this could lead to some cell therapeutic-based [...]

Filed under: Big Pharma, Innovation, stem cells | Tagged: , | 1 Comment »

  • Subscribe via email

    Subscribe to The Regeneration Station by Email

  • Top Posts

  • a

Follow

Get every new post delivered to your Inbox.